You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Klein Lawrence Otto · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$443.69K
Klein Lawrence Otto Chief Executive Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$92.11
Sep 1, 2026
First close after public filing
$91.63
Sep 2, 2026
30-day return after filing
-8.96%
Through Oct 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,800 shares @ $92.44
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000087
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$7.47M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Sale | Sep 1, 2026 | $443.69K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 1, 2026 | $585K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 1, 2026 | $599.56K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 1, 2026 | $5.84M |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 1, 2026 | $0 |